AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Tigecycline in South Africa
8 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TIGECYCLINE ADCO | 55/20.1.1/0750 | Adcock Ingram Limited | active | 9 May 2028 |
| CYTAGIL IV | 53/20.1.1/0715 | Pharma Dynamics (Pty) Ltd | active | 25 Apr 2028 |
| TIGECYCLINE 50 mg PFIZER | 53/20.1.1/0075 | Pfizer Laboratories (Pty) Ltd | active | 21 Feb 2028 |
| TACYL | 53/20.1.1/0630 | Teva Pharmaceuticals (Pty) Ltd | suspended | 18 Mar 2026 |
| GATICIL IV IV | 53/20.1.1/0716.715 | Pharma Dynamics (Pty) Ltd | suspended | 19 Jun 2023 |
| RUBICIL | 53/20.1.1/0730 | Ruby Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| TYGACIL | A40/20.1.1/0230 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| TIGEBAX | 54/20.1.1/0165 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 1 Jan 1900 |
Tigecycline — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Tigecycline, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Tigecycline registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.